Document is current
Any future updates will be listed below
-
Authors
Ammann, Markus
Kinney, Michelle A. O.
Gudmundsdottir, Hallbera
Santol, Jonas
Thiels, Cornelius A.
Warner, Susanne G.
Truty, Mark J.
Kendrick, Michael L.
Smoot, Rory L.
Anderson, Alexandra L.
Halfdanarson, Thorvardur R.
Nagorney, David M.
Starlinger, Patrick P.
- License Information
-
More Information
Article History
Received: 8 March 2024
Accepted: 10 March 2024
First Online: 15 April 2024
Disclosure
: Dr. Thor Halfdanarson received support from Thermo Fisher Scientific, Advanced Accelerator Applications (a Novartis company), Camurus, Crinetics, ITM Isotopen Technologien Muenchen, and Perspective Therapeutics. He served on the consultancy/advisory board/steering committees of Ipsen; TerSera, Advanced Accelerator Applications (a Novartis company, Terumo, ITM Isotopen Technologien Muenchen, Crinetics, Perspective Therapeutics, and Camurus. The remaining authors have no conflicts of interest.
